Evidence map›Paper›PMID 24931576›Full record

ArticleTraffic (Copenhagen, Denmark)2014

Mpl traffics to the cell surface through conventional and unconventional routes.

Cédric Cleyrat, Anza Darehshouri, Mara P Steinkamp, Mathias Vilaine, Daniela Boassa, Mark H Ellisman, Sylvie Hermouet, Bridget S Wilson

Open access · bronzeAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Review
  4. Article
  5. Article
  6. Review
  7. Myeloproliferative Neoplasms: Challenging Dogma.Journal of clinical medicine · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. TMED3 Complex Mediates ER Stress-Associated Secretion of CFTR, Pendrin, and SARS-CoV-2 Spike.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  12. Article
  13. Autophagy-Related Pathways in Vesicular Unconventional Protein Secretion.Frontiers in cell and developmental biology · 2022
    Review
  14. In and out: Traffic and dynamics of thrombopoietin receptor.Journal of cellular and molecular medicine · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Cédric CleyratDepartment of Pathology & Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM, 87131, USA; INSERM UMR892/CNRS UMR6299, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Institut de Recherche Thérapeutique-Université de Nantes, Nantes, 44000, France.
Anza Darehshouri
Mara P Steinkamp
Mathias Vilaine
Daniela Boassa
Mark H Ellisman
Sylvie Hermouet
Bridget S Wilson
Inserm · FRNew Mexico Cancer Center · USCentre National de la Recherche Scientifique · FRUniversity of California, San Diego · USUniversity of New Mexico · USUniversity of San Diego · US

Funding

VOLUMETRIC CONTOUR-BASED SURFACE RECONSTRUCTIONP41RR004050 · NCRR · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PASQUALE, ELENA B · 1989 to 2011
$28.0M
UNM TRAININGP50GM085273 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI EDWARDS, JEREMY S · 2009 to 2018
$26.1M
IVEM and Image Analysis ResourceP41GM103412 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLISMAN, MARK H · 2012 to 2019
$17.9M
Functional Analysis of the Sulfotransferase, SULT2B1F32GM065794 · NIGMS · INSTITUTE FOR CANCER RESEARCH · PI GEESE, WILLIAM J · 2002 to 2002
$31k
NCRR NIH HHS 5P41RR004050-24NCRR NIH HHS P41 RR004050NIGMS NIH HHS 8 P41 GM103412-24NIGMS NIH HHS F32 GM065794NIGMS NIH HHS P41 GM103412NIGMS NIH HHS P50GM065794NIGMS NIH HHS P50 GM085273
6 · The paper itself

Abstract

Myeloproliferative neoplasms (MPNs) are often characterized by JAK2 or calreticulin (CALR) mutations, indicating aberrant trafficking in pathogenesis. This study focuses on Mpl trafficking and Jak2 association using two model systems: human erythroleukemia cells (HEL; JAK2V617F) and K562 myeloid leukemia cells (JAK2WT). Consistent with a putative chaperone role for Jak2, Mpl and Jak2 associate on both intracellular and plasma membranes (shown by proximity ligation assay) and siRNA-mediated knockdown of Jak2 led to Mpl trapping in the endoplasmic reticulum (ER). Even in Jak2 sufficient cells, Mpl accumulates in punctate structures that partially colocalize with ER-tracker, the ER exit site marker (ERES) Sec31a, the autophagy marker LC3 and LAMP1. Mpl was fused to miniSOG, a genetically encoded tag for correlated light and electron microscopy. Results suggest that a fraction of Mpl is taken up into autophagic structures from the ER and routed to autolyososomes. Surface biotinylation shows that both immature and mature Mpl reach the cell surface; in K562 cells Mpl is also released in exosomes. Both forms rapidly internalize upon ligand addition, while recovery is primarily attributed to immature Mpl. Mpl appears to reach the plasma membrane via both conventional ER-Golgi and autolysosome secretory pathways, as well as recycling.

Indexed as

Cell Line, TumorCell MembraneEndoplasmic ReticulumExosomesHumansJanus Kinase 2K562 CellsLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsMicrotubule-Associated ProteinsProtein TransportReceptors, ThrombopoietinVesicular Transport ProteinsJAK2 protein, humanJanus Kinase 2LAMP1 protein, humanLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsMAP1LC3A protein, humanMicrotubule-Associated ProteinsMPL protein, humanReceptors, ThrombopoietinSEC31A protein, humanVesicular Transport ProteinsautophagyJAK2miniSOGMplMPNs

Identifiers

PMID24931576
PMCPMC4141020
OpenAlexW2018964965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.